OpenVSafe by OpenVAERS
Search V-safe

FXL-16121-25379

3 vaccinations 6 coded responses 21 check-ins 5 free-text entries 3 call cases
Sex
Female
Age at first dose
51-55
ZIP prefix
339 / FL
Registered
2021-04-05
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-05
    Registered in v-safe
  2. 2021-04-05
    Dose 1 — Pfizer-BioNTech
  3. 2021-04-05
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-04-06
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-04-07
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-04-08
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-04-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-04-11
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Diarrhea
    Adult check-in
  9. 2021-04-12
    Survey response — day 7, dose 1
    MedDRA: Oropharyngeal pain — Feeling: Fair · Fever · Fatigue or tiredness, Nausea
    Free text: Sore throat
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-04-19
    Survey response — day 14, dose 1
    MedDRA: Chest discomfort, Fatigue, Nausea, Oropharyngeal pain, Pyrexia — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Nausea, low grade fever, light sore throat, fatigue, light feeling of heaviness in chest. It is finally starting to subside.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-04-26
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-04-27
    Dose 2 — Pfizer-BioNTech
  13. 2021-05-03
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache
    Adult check-in
  14. 2021-05-04
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-05-11
    Health check-in — day 14, dose 2
    Feeling: Fair
    Adult check-in
  16. 2021-05-18
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-05-25
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-06-01
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-06-08
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-07-27
    Survey response — 3 months, dose 2
    MedDRA: Eye pain, Headache, Nausea, Office visit — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    Free text: Symptoms: NauseaPain behind eyesHeadache · Healthcare visit (other): In person appt primary physician
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  21. 2021-07-27
    Report sent to call center — 3 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  22. 2021-08-09
  23. 2021-10-28
    Survey response — 6 months, dose 2
    MedDRA: C-reactive protein increased, Inflammatory marker increased, Office visit, Red blood cell sedimentation rate increased — Feeling: Good · Get care from a doctor or other healthcare professional
    Free text: Symptoms: Bloodwork shows inflammation markers (SED rate and C-Reactive protein) as very high. This is new. · Healthcare visit (other): Appt with specialist
    MedDRA releases: 2024-11 · check-in free text available
  24. 2021-10-28
    Report sent to call center — 6 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  25. 2021-10-29
    Call successful
    Does not wish to fill out VAERS report
  26. 2022-01-04
    Dose 3 — Pfizer-BioNTech
  27. 2022-04-27
    Survey response — 12 months, dose 2
    MedDRA: Arthralgia, Burning sensation, Office visit, Paraesthesia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    Free text: Symptoms: Burning/tingling sensation all over body Joint pain Shoulder pain · Healthcare visit (other): Saw various doctors at doctor offices
    MedDRA releases: 2024-11 · check-in free text available
  28. 2022-04-27
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  29. 2022-04-29
  30. 2022-07-05
    Health check-in — 6 months, dose 3
    Feeling: Fair
    Adult check-in
  31. 2023-01-04
    Survey response — 12 months, dose 3
    MedDRA: COVID-19 — Feeling: Poor · Be unable to do your normal daily activities
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12021-04-05Pfizer-BioNTech
22021-04-27Pfizer-BioNTech
32022-01-04Pfizer-BioNTech No

Call center

3 call center cases

2 successful · 1 unsuccessful

See the call center timeline

Free text

Release 7 — day 7, dose 1

2021-04-12

Systemic reaction (other): Sore throat

Release 7 — day 14, dose 1

2021-04-19

Symptoms: Nausea, low grade fever, light sore throat, fatigue, light feeling of heaviness in chest. It is finally starting to subside.

Release 9 — 3 months, dose 2

2021-07-27

Symptoms: NauseaPain behind eyesHeadache
Healthcare visit (other): In person appt primary physician

Release 10 — 6 months, dose 2

2021-10-28

Symptoms: Bloodwork shows inflammation markers (SED rate and C-Reactive protein) as very high. This is new.
Healthcare visit (other): Appt with specialist

Release 11 — 12 months, dose 2

2022-04-27

Symptoms: Burning/tingling sensation all over body Joint pain Shoulder pain
Healthcare visit (other): Saw various doctors at doctor offices

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit ✓ · ✓
SDArthralgia · · ✓
SDBurning sensation · · ✓
SDC-reactive protein increased · · ✓
SDChest discomfort ✓ ✓ ✓
SDCOVID-19 · · ✓
SDEye pain ✓ · ✓
SDFatigue ✓ ✓ ✓
SDHeadache ✓ · ✓
SDInflammatory marker increased · · ✓
SDNausea ✓ ✓ ✓
SDOropharyngeal pain ✓ ✓ ✓
SDParaesthesia · · ✓
SDPyrexia ✓ ✓ ✓
SDRed blood cell sedimentation rate increased · · ✓
SROOropharyngeal pain ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release